USE OF FAVIPIRAVIR IN THE MANAGEMENT OF COVID-19 2020-08-26T18:32:11+02:00July 22nd, 2020|MAC Advisories - COVID-19| Advisory on Favipiravir-22 July 2020 Rapid Review of Favipiravir for COVID-19_25June2020 FacebookTwitterLinkedInWhatsAppEmail Related Posts ARE TRAVEL RESTRICTIONS WARRANTED IN LIGHT OF THE CURRENT SURGE IN COVID-19 CASES IN THE PEOPLE’S REPUBLIC OF CHINA? INTEGRATING COVID-19 DIAGNOSIS, PREVENTION AND CARE INTO ROUTINE HEALTHCARE SERVICES MAC ADVISORY: DIAGNOSIS, TREATMENT AND MANAGEMENT OF LONG COVID THE MENTAL HEALTH IMPACT OF COVID-19 ON SOUTH AFRICAN SOCIETY: HOW TO BUILD BACK BETTER
